BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34728141)

  • 1. Multimodal image-guided ablation on management of renal cancer in Von-Hippel-Lindau syndrome patients from 2004 to 2021 at a specialist centre: A longitudinal observational study.
    Chan VW; Lenton J; Smith J; Jagdev S; Ralph C; Vasudev N; Bhattarai S; Lewington A; Kimuli M; Cartledge J; Wah TM
    Eur J Surg Oncol; 2022 Mar; 48(3):672-679. PubMed ID: 34728141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irreversible electroporation (IRE) in renal cell carcinoma (RCC): a mid-term clinical experience.
    Wah TM; Lenton J; Smith J; Bassett P; Jagdev S; Ralph C; Vasudev N; Bhattarai S; Kimuli M; Cartledge J
    Eur Radiol; 2021 Oct; 31(10):7491-7499. PubMed ID: 33825033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous microwave ablation on management of hereditary renal cell carcinoma in Von Hippel-Lindau disease.
    Chen J; Zheng L; Zhang W; Wang Z; Yu J; Liang P
    Int J Hyperthermia; 2024; 41(1):2308079. PubMed ID: 38346873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeat Percutaneous Radiofrequency Ablation of T1 Renal Cell Carcinomas is Safe in Patients with Von Hippel-Lindau Disease.
    Wessendorf J; König A; Heers H; Mahnken AH
    Cardiovasc Intervent Radiol; 2021 Dec; 44(12):2022-2025. PubMed ID: 34414496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of renal tumors in Von Hippel-Lindau disease by percutaneous CT fluoroscopic guided radiofrequency ablation: preliminary results.
    Iwamoto Y; Kanda H; Yamakado K; Soga N; Arima K; Takeda K; Sugimura Y
    Fam Cancer; 2011 Sep; 10(3):529-34. PubMed ID: 21503747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephron sparing surgery in von Hippel-Lindau associated renal cell carcinoma; clinicopathological long-term follow-up.
    Jilg CA; Neumann HP; Gläsker S; Schäfer O; Leiber C; Ardelt PU; Schwardt M; Schultze-Seemann W
    Fam Cancer; 2012 Sep; 11(3):387-94. PubMed ID: 22426863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with von Hippel Lindau disease: indications, techniques, complications, and outcomes.
    Park BK; Kim CK; Park SY; Shen SH
    Acta Radiol; 2013 May; 54(4):418-27. PubMed ID: 23446745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probe ablation as salvage therapy for renal tumors in von Hippel-Lindau patients: the Cleveland Clinic experience with 3 years follow-up.
    Yang B; Autorino R; Remer EM; Laydner HK; Hillyer S; Altunrende F; White MA; Khanna R; Stein RJ; Haber GP; O'Malley CM; Kaouk JH
    Urol Oncol; 2013 Jul; 31(5):686-92. PubMed ID: 21723752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncological and Peri-Operative Outcomes of Percutaneous Cryoablation of Renal Cell Carcinoma for Patients with Hereditary RCC Diseases-An Analysis of European Multi-Centre Prospective EuRECA Registry.
    Osman FH; Chan VW; Breen DJ; King A; Nielsen TK; Garnon J; Alcorn D; Lagerveld B; Graumann O; Keeley FX; Walkden M; de Kerviler É; Wah TM
    Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous radio frequency ablation of renal tumors in patients with von Hippel-Lindau disease: preliminary results.
    Park BK; Kim CK
    J Urol; 2010 May; 183(5):1703-7. PubMed ID: 20299060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous ultrasound-guided radiofrequency ablation treatment and genetic testing for renal cell carcinoma with Von Hippel-Lindau disease.
    Gao Y; Xu M; Xu ZF; Liu DW; Tu XA; Zheng YL; Wang DH; Sun XZ; Zheng FF; Qiu SP; Lü MD; Zhang YY; Xie XY; Deng CH
    J Xray Sci Technol; 2012; 20(1):121-9. PubMed ID: 22398592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of intervention for renal lesions in von Hippel-Lindau disease.
    Matin SF; Ahrar K; Wood CG; Daniels M; Jonasch E
    BJU Int; 2008 Sep; 102(8):940-5. PubMed ID: 18485044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of renal cell carcinoma in von Hippel-Lindau disease.
    Hes FJ; Slootweg PJ; van Vroonhoven TJ; Hené RJ; Feldberg MA; Zewald RA; Ploos van Amstel JK; Höppener JW; Pearson PL; Lips CJ
    Eur J Clin Invest; 1999 Jan; 29(1):68-75. PubMed ID: 10092992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease.
    Blute ML; Amling CL; Bryant SC; Zincke H
    Mayo Clin Proc; 2000 Oct; 75(10):1020-6. PubMed ID: 11040850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal cell carcinoma in von Hippel-Lindau disease. Nephron sparing surgery.].
    Urbieta Anza A; Llarena Ibarguren R; Tomás Zabala Egurrola JA; Gutierrez Zurimendi G; Iturregui Del Pozo AM; Arruza Echevarria A
    Arch Esp Urol; 2018 Nov; 71(9):757-764. PubMed ID: 30403378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency Ablation for Renal Cancer in Von Hippel-Lindau Syndrome Patients: A Prospective Cohort Analysis.
    Allasia M; Soria F; Battaglia A; Gazzera C; Calandri M; Caprino MP; Lucatello B; Velrti A; Maccario M; Pasini B; Bosio A; Gontero P; Destefanis P
    Clin Genitourin Cancer; 2017 Aug; ():. PubMed ID: 28866246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of and indications for renal transplantation in patients with von Hippel Lindau disease.
    Antony MB; Rompré-Brodeur A; Chaurasia A; Ryan B; Gopal N; Kozel Z; Linehan WM; Ball MW
    Urol Oncol; 2023 Dec; 41(12):487.e1-487.e6. PubMed ID: 37778955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surgical treatment of renal-cell carcinoma in von Hippel-Lindau disease].
    Uscanga-Yépez J; Rodríguez-Covarrubias F; Morales J; Granados J; Gabilondo-Navarro F
    Rev Invest Clin; 2013; 65(4):318-22. PubMed ID: 24304732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal tumor size is an independent prognostic factor for overall survival in von Hippel-Lindau disease.
    Kwon T; Jeong IG; Pak S; You D; Song C; Hong JH; Ahn H; Kim CS
    J Cancer Res Clin Oncol; 2014 Jul; 140(7):1171-7. PubMed ID: 24671227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours.
    Wah TM; Irving HC; Gregory W; Cartledge J; Joyce AD; Selby PJ
    BJU Int; 2014 Mar; 113(3):416-28. PubMed ID: 24053769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.